Delivery Order SPE2DB22D2206-SPE2DB24FJM79

Award Date 7/30/24
Potential Completion Date 7/31/24
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order with a ceiling value of $12,793.33, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CONCERTA ER 18 MG TABLET 100S, a prescription medication. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a $13,971.49 firm-fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of CONCERTA ER 18 MG TABLET 100S, a prescription medication, to support federal healthcare programs. This award is under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $45,340.11, is for the provision of CONCERTA ER 18 MG TABLET 100S, a prescription medication. The contract has a completion date of June 14, 2023 and is a firm fixed-price arrangement. This contract award is not designated as a set-aside procurement....
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,042.45, is for the delivery of CONCERTA ER 18 MG TABLET 100S, a specialty pharmaceutical product. The contract is a delivery order placed under an existing Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $12,161.29 for the provision of 4567360063 - CONCERTA ER 18 MG TABLET 100S. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of February 25, 2025. The contract is a firm fixed price delivery order and is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award is for a delivery order placed with AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of CONCERTA ER 18 MG TABLET 100S, a pharmaceutical product, to support military healthcare programs. The award has a ceiling value of $1,756.96 and an ultimate completion date of January 15, 2025. The contract is a Firm Fixed Price (FFP) delivery order, with no set-aside designation indicated....
This federal contract award is for the delivery of CONCERTA ER 27 MG TABLET 100S to the Defense Logistics Agency (DLA). The contract, valued at $8,710.22, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order with a period of performance through November 12, 2024. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award, valued at $7,727.87, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is a $999,999,999 contract running through November 2026. This IDC enables the DLA to efficiently procure a comprehensive range of pharmaceutical products and medical supplies,...
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is a Firm Fixed Price Delivery Order valued at $8,568.12 for the supply of CONCERTA ER 27 MG TABLET 100S. The contract was awarded by the Defense Logistics Agency (DLA) and has an ultimate completion date of September 18, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which enables the...
This federal contract award from the Defense Logistics Agency (DLA) was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide CONCERTA ER 36 MG TABLET 100S. The firm-fixed-price Delivery Order, valued at $7,089.92, has a completion date of September 20, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FJM79
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of CONCERTA ER 18 MG TABLET 100S to the Defense Logistics Agency (DLA). The award, valued at $11,947.26, is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of up to $999,999,999 through December 2025. The contract is for a firm fixed price and does not have a set-aside designation. This award supports the DLA's role in supplying critical pharmaceutical and medical products to military treatment facilities and other federal healthcare providers nationwide.

Generated 10/29/24, 9:19 AM